Real Estate Stocks Edge Down, While Major Market Averages Gain Marginally
Healthpeak Properties Announces Second Quarter 2024 Earnings Release Date and Conference Call Details
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report its second quarter 2024 financial results after the close of
Healthpeak Properties Publishes Its 13th Annual Corporate Impact Report
Healthpeak Properties, Inc. ("Healthpeak") (NYSE: DOC) announced today that it has published its 13th annual Corporate Impact Report (the "Report"), formerly called the ESG Report. The shift in the title of the Report reflects a more comprehensive approach to corporate responsibility and sustainability, underscoring Healthpeak's commitment to, and broader impact on, stakeholders and communities beyond environmental, social, and governance factors.
Citigroup Adjusts Price Target on Healthpeak Properties to $20 From $18
Citigroup Adjusts Price Target on Healthpeak Properties to $20 From $18.
Express News | NYSE Order Imbalance 62255.0 Shares on Sell Side
Real Estate Stocks Gain After Inflation Report Even as Major Market Averages Lose
Express News | NYSE Order Imbalance 481624.0 Shares on Buy Side
Healthpeak Properties to Present at Nareit's REITweek 2024 Investor Conference
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that Scott Brinker, President and Chief Executive Officer, and Peter
Express News | NYSE Order Imbalance 122711.0 Shares on Sell Side
Express News | NYSE Order Imbalance 118487.0 Shares on Sell Side
Express News | NYSE Order Imbalance 144895.0 Shares on Sell Side
Are Wall Street Analysts Bullish on Healthpeak Properties Stock?
Real Estate Stocks Fall After 4 Weeks of Gain as Rate Cut Hopes Dampen
Express News | NYSE Order Imbalance 50520.0 Shares on Buy Side
Real Estate Stocks Continue to Surge as Soft Inflation Reports Fuel Rate Cut Hopes
J.P. Morgan Sticks to Their Hold Rating for Healthpeak Properties (DOC)
Cracking The Code: Understanding Analyst Reviews For Healthpeak Properties
Analysts' ratings for Healthpeak Properties (NYSE:DOC) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The table below provides a snapshot of their recent ratings, showca
Scotiabank Maintains Sector Outperform on Healthpeak Properties, Raises Price Target to $23
Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties with a Sector Outperform and raises the price target from $22 to $23.
Healthpeak Properties Is Maintained at Neutral by JP Morgan
Healthpeak Properties Is Maintained at Neutral by JP Morgan
Komo: Maintaining the Healthpeak Properties (DOC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $19.00 to $21.00.
Komo: Maintaining the Healthpeak Properties (DOC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $19.00 to $21.00.